Venous thromboembolism and pregnancy: A review of the literature
), Karim AM Ahmed(2), Mohd NH Daud(3), Aya M. Eldiasty(4), Mohdamed FB Amri(5), Mohammad SB Jeffree(6), Fairrul B Kadir(7), Dayang MP Baharuddin(8), Syed SB Abdul Rahim(9), Win W Than(10), Firdaus M Hayati(11), Nornazirah B Azizan(12), Doreen Sumpat(13), May Z Soe(14),
(1) Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Malaysia
(2) Department of Dermatology, Helios Saint Johannes Klinikum, Duisburg, Germany
(3) Department of Family Medicine , Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Malaysia
(4) Department of Dermatology, Helios Saint Johannes Klinikum, Duisburg, Germany
(5) Department of Pathology and Microbiology, Faculty of Medicine and Health Sciences,University Malaysia Sabah,Malaysia
(6) Department of Public Health Medicine, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Malaysia
(7) Department of Emergency Medicine, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Malaysia
(8) Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Malaysia
(9) Department of Public Health Medicine, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Malaysia
(10) Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Malaysia
(11) Department of Surgery, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia
(12) Department of Clinical Pathology, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Malaysia
(13) Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Malaysia
(14) Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Malaysia
Corresponding Author
Abstract
References
Pomp ER, Lenselink AM, Rosendaal FR and Doggen CJM. “Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study,” J Thromb Haemost, vol. 6, no. 4, pp. 632–637, Apr. 2008, doi: 10.1111/J.1538-7836.2008.02921.X.
Barco S, Nijkeuter M and Middeldorp S. “Pregnancy and venous thromboembolism,” Semin Thromb Hemost, vol. 39, no. 5, pp. 549–558, 2013, doi: 10.1055/S-0033-1343893.
James AH, Jamison MG, Brancazio LR and Myers ER. “Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality,” Am J Obstet Gynecol, vol. 194, no. 5, pp. 1311–1315, May 2006, doi: 10.1016/J.AJOG.2005.11.008.
Silvis SM, Lindgren E, Hiltunen S, Devasagayam S, Scheres LJ and Jood K. “Postpartum period is a risk factor for cerebral venous thrombosis: A case-control study,” Stroke, vol. 50, no. 2, pp. 501–503, 2019, doi:10.1161/STROKEAHA.118.023017.
Pabinger I, Grafenhofer H, Kyrle PA, Quehenberger P, Mannhalter C, Lechner K and Kaider A. “Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism,” Blood, vol. 100, no. 3, pp. 1060–1062, Aug. 2002, doi: 10.1182/BLOOD-2002-01-0149.
Brill-Edwards P, Ginsberg JS, Gent M, Hirsh J, Burrows R, Kearon C, Geerts W, Kovacs M, Weitz JI, Robinson KS, Whittom R and Couture G. “Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group,” N Engl J Med, vol. 343, no. 20, pp. 1439–1444, Nov. 2000, doi: 10.1056/NEJM200011163432002.
De Stefano V, Martinelli I, Rossi E, Battaglioli T, Za T, Mannucci PM and Leone G. “The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis,” Br J Haematol, vol. 135, no. 3, pp. 386–391, Nov. 2006, doi: 10.1111/J.1365-2141.2006.06317.X.
White RH, Murin S, Wun T and Danielsen B. “Recurrent venous thromboembolism after surgery-provoked versus unprovoked thromboembolism,” Journal of Thrombosis and Haemostasis, vol. 8, no. 5, pp. 987–997, 2010, doi: 10.1111/j.1538-7836.2010.03798.x.
Gerhardt A, Scharf RE, Greer IA and Zotz RB. “Hereditary risk factors for thrombophilia and probability of venous thromboembolism during pregnancy and the puerperium,” Blood, vol. 128, no. 19, pp. 2343–2349, Nov. 2016, doi: 10.1182/BLOOD-2016-03-703728.
Folkeringa N, Brouwer JLP, Korteweg FJ, Veeger NJGM, Erwich JJHM and van der Meer J, “High risk of pregnancy-related venous thromboembolism in women with multiple thrombophilic defects,” Br J Haematol, vol. 138, no. 1, pp. 110–116, Jul. 2007, doi: 10.1111/J.1365-2141.2007.06624.X.
Stevens SM, Woller SC, Bauer KA, Kasthuri R, Cushman M, Streiff M, Lim W and Douketis JD. “Guidance for the evaluation and treatment of hereditary and acquired thrombophilia,” J Thromb Thrombolysis, vol. 41, no. 1, pp. 154–164, Jan. 2016, doi: 10.1007/S11239-015-1316-1.
Jacobsen AF, Skjeldestad FE and Sandset PM, “Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study,” J Thromb Haemost, vol. 6, no. 6, pp. 905–912, 2008, doi: 10.1111/J.1538-7836.2008.02961.X.
Robertson L, Wu O, Langhorne P, waddle ST, Clark P, Lowe GDO, Walker ID, Greaves M, Brenkel I, Regan L and Greer IA, “Thrombophilia in pregnancy: a systematic review,” Br J Haematol, vol. 132, no. 2, pp. 171–196, Jan. 2006, doi: 10.1111/J.1365-2141.2005.05847.X.
Hart C, Bauersachs R, Scholz U, Zotz R, Bergmann F, Rott H and Linnemann B. “Prevention of Venous Thromboembolism during Pregnancy and the Puerperium with a Special Focus on Women with Hereditary Thrombophilia or Prior VTE-Position Paper of the Working Group in Women’s Health of the Society of Thrombosis and Haemostasis (GTH),” Hamostaseologie, vol. 40, no. 5. Georg Thieme Verlag, pp. 572–590, Dec. 01, 2020. doi: 10.1055/a-1132-0750.
Bezemer ID, van der Meer FJM, Eikenboom JCJ, Rosendaal FR and Doggen CJM, “The value of family history as a risk indicator for venous
Abdelhafez et al. VTE and pregnancy
African Journal of Reproductive Health May 2023; 27 (5):
thrombosis,” Arch Intern Med, vol. 169, no. 6, pp. 610–615, Mar. 2009, doi: 10.1001/ARCHINTERNMED.2008.589.
Blondon M, Casini A, Hoppe KK, Boehlen F, Righini M and Smith NL. “Risks of Venous Thromboembolism After Cesarean Sections: A Meta-Analysis,” Chest, vol. 150, no. 3, pp. 572–596, Sep. 2016, doi: 10.1016/J.CHEST.2016.05.021.
Ducloy-Bouthors AS, Baldini A, Abdul-Kadir R and Nizard J. “European guidelines on perioperative venous thromboembolism prophylaxis,” Eur J Anaesthesiol, vol. 35, no. 2, pp. 130–133, Feb. 2018, doi: 10.1097/EJA.0000000000000704.
Yelnik CM, Urbanski G, Drumez E, Sobanski V, Maillard H, Lanteri A, Morell-Dubois S, Caron C, Dubucquoi S, Launay D, Duhamel A, Hachulla E, P Y Hatron ,and M Lambert , “Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity,” Lupus, vol. 26, no. 2, pp. 163–169, Feb. 2017, doi: 10.1177/0961203316657433.
Simpson EL, Lawrenson RA, A. Nightingale AL and Farmer RDT. “Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database,” BJOG, vol. 108, no. 1, pp. 56–60, Jan. 2001, doi: 10.1111/J.1471-0528.2001.00004.X.
Lindqvist P, Dahlbäck B and Marŝál K. “Thrombotic risk during pregnancy: a population study,” Obstetrics and gynecology, vol. 94, no. 4, pp. 595–599, Oct. 1999, doi: 10.1016/S0029-7844(99)00308-7.
Larsen TB, Sørensen HT, Gislum M and Johnsen SP. “Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study,” Thromb Res, vol. 120, no. 4, pp. 505–509, 2007, doi: 10.1016/J.THROMRES.2006.12.003.
Robinson HE, O’Connell CM, Joseph KS and McLeod NL. “Maternal outcomes in pregnancies complicated by obesity,” Obstetrics and gynecology, vol. 106, no. 6, pp. 1357–1364, 2005, doi: 10.1097/01.AOG.0000188387.88032.41.
Jacobsen AF, Skjeldestad FE, and Sandset PM. “Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study,” J Thromb Haemost, vol. 6, no. 6, pp. 905–912, 2008, doi: 10.1111/J.1538-7836.2008.02961.X.
Sultan AA, West J, Tata LJ, Fleming KM, Nelson-Piercy C and Grainge MJ. “Risk of first venous thromboembolism in pregnant women in hospital: population based cohort study from England,” BMJ, vol. 347, 2013, doi: 10.1136/BMJ.F6099.
Bates SM, Greer A, Middeldorp S, Veenstra DL, Prabulos AM and Vandvik PO. “VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,” Chest, vol. 141, no. 2 Suppl, pp. e691S-e736S, 2012, doi: 10.1378/CHEST.11-2300.
Wee-Shian Chan, Evelyne Rey, Nancy E Kent, VTE in Pregnancy Guideline Working Group; Wee-Shian Chan, Nancy E Kent, Evelyne Rey, Thomas Corbett, Michèle David, M Joanne Douglas, Paul S Gibson, Laura Magee, Marc Rodger and Reginald E Smith, “Venous thromboembolism and antithrombotic therapy in pregnancy,” J Obstet Gynaecol Can, vol. 36, no. 6, pp. 527–553, 2014, doi: 10.1016/S1701-2163(15)30569-7.
Bauersachs RM, Manolopoulos K, Hoppe I, Arin MJ and Schleussner E. “More on: the ‘ART’ behind the clot: solving the mystery,” J Thromb Haemost, vol. 5, no. 2, pp. 438–439, Feb. 2007, doi: 10.1111/J.1538-7836.2007.02339.X.
Chan SW and Ginsberg JS. “A review of upper extremity deep vein thrombosis in pregnancy: unmasking the ‘ART’ behind the clot,” J Thromb Haemost, vol. 4, no. 8, pp. 1673–1677, Aug. 2006, doi: 10.1111/J.1538-7836.2006.02026.X.
Mohammed A Alsheef, Alhanouf M Alabbad , Rowida A Albassam , Rawan M Alarfaj , Abdul Rehman Z Zaidi , Ohoud Al-Arfaj ,and Amani Abu-Shaheen , “Pregnancy and Venous Thromboembolism: Risk Factors, Trends, Management, and Mortality,” Biomed Res Int, vol. 2020, 2020, doi: 10.1155/2020/4071892.
Okoroh EM, Azonobi IC, Grosse SD, Grant AM, Atras HK and James AH. “Prevention of venous thromboembolism in pregnancy: a review of guidelines, 2000-2011,” J Womens Health (Larchmt), vol. 21, no. 6, pp. 611–615, Jun. 2012, doi: 10.1089/JWH.2012.3600.
Hoffman R and Brenner B. “Can we program VTE prevention in pregnancy?” Intern Emerg Med, vol. 10, no. 2, pp. 123–124, Mar. 2015, doi: 10.1007/s11739-014-1184-2.
“ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy,” Obstetrics and gynecology, vol. 132, no. 1, pp. e1–e17, Jul. 2018, doi: 10.1097/AOG.0000000000002706.
Bates SM, Greer A, Middeldorp S, Veenstra DL, Prabulos AM and Vandvik PO. “VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,” Chest, vol. 141, no. 2 Suppl, pp. e691S-e736S, 2012, doi: 10.1378/CHEST.11-2300.
Nelson-Piercy C, MacCallum P and Mackillop L, for the Royal College of Obstetricians and Gynaecologists. Reducing the risk of venous thromboembolism in pregnancy and the puerperium. Green-top Guideline No. 37a. London: RCOG; 2015”.
Shannon M Bates, Anita Rajasekhar, Saskia Middeldorp, Claire McLintock, Marc A Rodger, Andra H James, Sara R Vazquez, Ian A Greer, John J Riva, Meha Bhatt, Nicole Schwab, Danielle Barrett, Andrea LaHaye and, Bram Rochwerg, “American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy,”
Abdelhafez et al. VTE and pregnancy
African Journal of Reproductive Health May 2023; 27 (5):
Blood Adv, vol. 2, no. 22, pp. 3317–3359, Nov. 2018, doi: 10.1182/BLOODADVANCES.2018024802.
Wee-Shian Chan, Evelyne Rey, Nancy E Kent. VTE in Pregnancy Guideline Working Group; Wee-Shian Chan, Nancy E Kent, Evelyne Rey, Thomas Corbett, Michèle David, M Joanne Douglas, Paul S Gibson, Laura Magee, Marc Rodger, and Reginald E Smith, “Venous thromboembolism and antithrombotic therapy in pregnancy,” J Obstet Gynaecol Can, vol. 36, no. 6, pp. 527–553, 2014, doi: 10.1016/S1701-2163(15)30569-7.
Bates SM, Middeldorp S, Rodger M, James AH and Greer I. “Guidance for the treatment and prevention of obstetric-associated venous thromboembolism,” J Thromb Thrombolysis, vol. 41, no. 1, pp. 92–128, Jan. 2016, doi: 10.1007/S11239-015-1309-0.
Mark H Eckman , Pablo Alonso-Coello, Gordon H Guyatt, Shanil Ebrahim, Kari A O Tikkinen, Luciane Cruz Lopes, Ignacio Neumann, Sarah D McDonald, Yuqing Zhang , Qi Zhou, Elie A Akl, Ann Flem Jacobsen, Amparo Santamaría, Joyce Maria Annichino-Bizzacchi, Wael Bitar, Per Morten Sandset and Shannon M Bates , “Women’s values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities,” Thromb Res, vol. 136, no. 2, pp. 341–347, Aug. 2015, doi: 10.1016/J.THROMRES.2015.05.020.
“ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy,” Obstetrics and gynecology, vol. 132, no. 1, pp. e1–e17, Jul. 2018, doi: 10.1097/AOG.0000000000002706.
Skeith L. “Preventing venous thromboembolism during pregnancy and postpartum: crossing the threshold,” Hematology Am Soc Hematol Educ Program, vol. 2017, no. 1, pp. 160–167, Dec. 2017, doi: 10.1182/ASHEDUCATION-2017.1.160.
Bates SM, Middeldorp S, Rodger M, James AH and Greer I. “Guidance for the treatment and prevention of obstetric-associated venous thromboembolism,” J Thromb Thrombolysis, vol. 41, no. 1, pp. 92–128, Jan. 2016, doi: 10.1007/S11239-015-1309-0.
Friederich PW, Sanson BJ, Simioni P, Zanardi S, Huisman MV, Kindt I, Prandoni P, Büller HR, Girolami A and Prins MH. “Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis,” Ann Intern Med, vol. 125, no. 12, pp. 955–960, 1996, doi: 10.7326/0003-4819-125-12-199612150-00003.
Mahmoodi BK, Brouwer J-LP, Ten Kate MK, Lijfering WM, Veeger NJGM, Mulder AB, Kluin-Nelemans HC and Van Der Meer J. “A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin,” J Thromb Haemost, vol. 8, no. 6, pp. 1193–1200, Jun. 2010, doi: 10.1111/J.1538-7836.2010.03840.X.
Ben Pearson-Stuttard, Catherine Bagot, Etienne Ciantar,
Bethan Myers, Rosalyn Davies, Rachel Rayment, Amanda Clark, Angela McKernan, and Sue Pavord, “Severe antithrombin deficiency in pregnancy: Achieving adequate anticoagulation,” Obstet Med, vol. 12, no. 1, pp. 45–51, Mar. 2019, doi: 10.1177/1753495X17741025.
Birgit Linnemann, Ute Scholz, Hannelore Rott, Susan Halimeh, Rainer Zotz, Andrea Gerhardt, Bettina Toth, and Rupert Bauersachs, “Treatment of pregnancy-associated venous thromboembolism - position paper from the Working Group in Women’s Health of the Society of Thrombosis and Haemostasis (GTH),” Vasa, vol. 45, no. 2, pp. 103–118, Apr. 2016, doi: 10.1024/0301-1526/A000504.
Chan WS, Anand S and Ginsberg JS. “Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature,” Arch Intern Med, vol. 160, no. 2, pp. 191–196, Jan. 2000, doi: 10.1001/ARCHINTE.160.2.191.
Jan Beyer-Westendorf, Franziska Michalski, Luise Tittl, Saskia Middeldorp, Hannah Cohen, Rezan Abdul Kadir, Deepa Jayakody Arachchillage, Roopen Arya, Cihan Ay,and Sandra Marten , “Pregnancy outcome in patients exposed to direct oral anticoagulants - and the challenge of event reporting,” Thromb Haemost, vol. 116, no. 4, pp. 651–658, Oct. 2016, doi: 10.1160/TH16-04-0305.
Cohen H, Arachchillage DR, Middeldorp S, Beyer-Westendorf J, and Abdul-Kadir R. “Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH,” J Thromb Haemost, vol. 14, no. 8, pp. 1673–1676, Aug. 2016, doi: 10.1111/JTH.13366.
Lameijer H, Aalberts JJJ, van Veldhuisen DJ, Meijer K and Pieper PG. “Efficacy and safety of direct oral anticoagulants during pregnancy; a systematic literature review,” Thromb Res, vol. 169, pp. 123–127, Sep. 2018, doi: 10.1016/J.THROMRES.2018.07.022.
Haas S, Encke A and Kopp I. “German S3 guideline for the prevention of venous thromboembolism updated Comment on Vasa Supplement 92,” Vasa, vol. 45, no. 5, pp. 347–348, Sep. 2016, doi: 10.1024/0301-1526/A000559.
Pettilä V, Kaaja R, Leinonen P, Ekblad U, Kataja M and Ikkala E, “Thromboprophylaxis with low molecular weight heparin (dalteparin) in pregnancy,” Thromb Res, vol. 96, no. 4, pp. 275–282, Nov. 1999, doi: 10.1016/S0049-3848(99)00110-3.
Quinlan DJ, McQuillan A and Eikelboom JW. “Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials,” Ann Intern Med, vol. 140, no. 3, Feb. 2004, doi: 10.7326/0003-4819-140-3-200402030-00008.
Catherine Nelson-Piercy, Raymond Powrie, Jean-Yvonne Borg, Marc Rodger, David J Talbot, John Stinson, and Ian A Greer, “Tinzaparin use in pregnancy: an international, retrospective study of the safety and
Abdelhafez et al. VTE and pregnancy
African Journal of Reproductive Health May 2023; 27 (5):
efficacy profile,” Eur J Obstet Gynecol Reprod Biol, vol. 159, no. 2, pp. 293–299, 2011, doi: 10.1016/J.EJOGRB.2011.08.005.
Romualdi E, Dentali F, Rancan E, Squizzato A, Steidl L, Middeldorp S, and Ageno W, “Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature,” J Thromb Haemost, vol. 11, no. 2, pp. 270–281, Feb. 2013, doi: 10.1111/JTH.12085.
Greer IA and Nelson-Piercy C. “Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy,” Blood, vol. 106, no. 2, pp. 401–407, Jul. 2005, doi: 10.1182/BLOOD-2005-02-0626.
Gould MK, Dembitzer AD, Doyle RI, Hastie TJ and Garber AM. “Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials,” Ann Intern Med, vol. 130, no. 10, pp. 800–809, May 1999, doi: 10.7326/0003-4819-130-10-199905180-00003.
Roeters Van Lennep JE, Meijer E, Klumper FJCM, Middeldorp JM, Bloemenkamp KWM and Middeldorp S. “Prophylaxis with low-dose low-molecular-weight heparin during pregnancy and postpartum: is it effective?,” J Thromb Haemost, vol. 9, no. 3, pp. 473–480, Mar. 2011, doi: 10.1111/J.1538-7836.2011.04186.X.
Lebaudy C, Hulot JS, Amoura Z, Costedoat-Chalumeau N, Serreau R, Ankri A, Conard J, Cornet A, Dommergues M, Piette JC and Lechat.P. “Changes in enoxaparin pharmacokinetics during pregnancy and implications for antithrombotic therapeutic strategy,” Clin Pharmacol Ther, vol. 84, no. 3, pp. 370–377, Sep. 2008, doi: 10.1038/CLPT.2008.73.
Barbour IA, Oja JL and Schultz IK. “A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation,” in American Journal of Obstetrics and Gynecology, Sep. 2004, vol. 191, no. 3, pp. 1024–1029. doi: 10.1016/j.ajog.2004.05.050.
Rodger MA, Kahn SR, Cranney A, Hodsman A, Kovacs MJ, Clement AM, Lazo-Langner A and Hague WM. “Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial,” J Thromb Haemost, vol. 5, no. 8, pp. 1600–1606, Aug. 2007, doi: 10.1111/J.1538-7836.2007.02634.X.
Lori-Ann Linkins, Antonio L Dans, Lisa K Moores, Robert Bona, Bruce L Davidson, Sam Schulman and Mark Crowther, “Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,” Chest, vol. 141, no. 2 Suppl, pp. e495S-e530S, 2012, doi: 10.1378/CHEST.11-2303.
Garcia DA, Baglin TP, JWeitz JL and Samama MM. “Parenteral anticoagulants: Antithrombotic Therapy
and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,” Chest, vol. 141, no. 2 Suppl, pp. e24S-e43S, 2012, doi: 10.1378/CHEST.11-2291.
Bates SM and Ginsberg JS. “How we manage venous thromboembolism during pregnancy,” Blood, vol. 100, no. 10, pp. 3470–3478, Nov. 2002, doi: 10.1182/BLOOD-2002-03-0965.
Magnani HN. “An analysis of clinical outcomes of 91 pregnancies in 83 women treated with danaparoid (Orgaran),” Thromb Res, vol. 125, no. 4, pp. 297–302, Apr. 2010, doi: 10.1016/J.THROMRES.2009.06.006.
Knol HM, Schultinge L, Erwich JJHM, and Meijer K. “Fondaparinux as an alternative anticoagulant therapy during pregnancy,” J Thromb Haemost, vol. 8, no. 8, pp. 1876–1879, Aug. 2010, doi: 10.1111/J.1538-7836.2010.03926.X.
Gerhardt A, Zotz RB, Stockschlaeder M and Scharf RE. “Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids [3],” Thrombosis and Haemostasis, vol. 97, no. 3. pp. 496–497, Mar. 2007. doi: 10.1160/TH06-10-0577.
Limmer JS, Grotegut CA, Thames E, Dotters-Katz SK, Brancazio IR and James AH. “Postpartum wound and bleeding complications in women who received peripartum anticoagulation,” Thromb Res, vol. 132, no. 1, Jul. 2013, doi: 10.1016/J.THROMRES.2013.04.034.
Birgit Linnemann, Ute Scholz, Hannelore Rott, Susan Halimeh, Rainer Zotz, Andrea Gerhardt, Bettina Toth, and Rupert Bauersachs “Treatment of pregnancy-associated venous thromboembolism - position paper from the Working Group in Women’s Health of the Society of Thrombosis and Haemostasis (GTH),” Vasa, vol. 45, no. 2, pp. 103–118, Apr. 2016, doi: 10.1024/0301-1526/A000504.
Bauersachs RM, Manolopoulos K, Hoppe I, Arin MJ and Schleussner E. “More on: the ‘ART’ behind the clot: solving the mystery,” J Thromb Haemost, vol. 5, no. 2, pp. 438–439, Feb. 2007, doi: 10.1111/J.1538-7836.2007.02339.X.
Chan WS and Ginsberg JS. “A review of upper extremity deep vein thrombosis in pregnancy: unmasking the ‘ART’ behind the clot,” J Thromb Haemost, vol. 4, no. 8, pp. 1673–1677, Aug. 2006, doi: 10.1111/J.1538-7836.2006.02026.X.
Bergrem A, Jacobsen EM, Skjeldestad FE, Jacobsen AF, Skogstad M and Sandset PM. “The association of antiphospholipid antibodies with pregnancy-related first time venous thrombosis--a population-based case-control study,” Thromb Res, vol. 125, no. 5, 2010, doi: 10.1016/J.THROMRES.2009.12.006.
Ducloy-Bouthors AS, Baldini A, Abdul-Kadir R and Nizard J. “European guidelines on perioperative venous thromboembolism prophylaxis: Surgery during pregnancy and the immediate postpartum
Abdelhafez et al. VTE and pregnancy
African Journal of Reproductive Health May 2023; 27 (5):
period,” Eur J Anaesthesiol, vol. 35, no. 2, pp. 130–133, Feb. 2018, doi: 10.1097/EJA.0000000000000704.
Haas S, Encke A and Kopp I. “German S3 guideline for the prevention of venous thromboembolism updated Comment on Vasa Supplement 92,” Vasa, vol. 45, no. 5, pp. 347–348, Sep. 2016, doi: 10.1024/0301-1526/A000559.
Gogarten W, Vandermeulen E, van Aken H, Kozek S, Llau JV and Samama CM. “Regional anaesthesia and antithrombotic agents: Recommendations of the European Society of Anaesthesiology,” European Journal of Anaesthesiology, vol. 27, no. 12. pp. 999–1015, Dec. 2010. doi: 10.1097/EJA.0b013e32833f6f6f.
Cohen H, Arachchillage DR, Middeldorp S, Beyer-Westendorf J and Abdul-Kadir R. “Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH: reply,” J Thromb Haemost, vol. 15, no. 1, pp. 195–197, Jan. 2017, doi: 10.1111/JTH.13535.
Kearsley R and Stocks G, “Venous thromboembolism in pregnancy—diagnosis, management, and treatment,” BJA Education, vol. 21, no. 3. Elsevier Ltd, pp. 117–123, Mar. 01, 2021. doi: 10.1016/j.bjae.2020.10.003.
Chan WS, Spencer FA and Ginsberg JS. “Anatomic distribution of deep vein thrombosis in pregnancy,” CMAJ, vol. 182, no. 7, pp. 657–660, Apr. 2010, doi: 10.1503/CMAJ.091692.
Omar Touhami, Sofiene Ben Marzouk, Laidi Bennasr, Maha Touaibia, Iheb Souli, Mohamed Amine Felfel, Mehdi Kehila , Mohamed Badis Channoufi ,and Hayen El Magherbi , “Are the Wells Score and the Revised Geneva Score valuable for the diagnosis of pulmonary embolism in pregnancy?,” Eur J Obstet Gynecol Reprod Biol, vol. 221, pp. 166–171, Feb. 2018, doi: 10.1016/J.EJOGRB.2017.12.049.
Chu J, Johnston TA and Geoghegan J. “Maternal Collapse in Pregnancy and the Puerperium: Green-top Guideline No. 56,” BJOG, vol. 127, no. 5, pp. e14–e52, Apr. 2020, doi: 10.1111/1471-0528.15995.
Simcox LE, Ormesher L, Tower C and Greer IA. “Pulmonary thrombo-embolism in pregnancy: Diagnosis and management,” Breathe, vol. 11, no. 4. European Respiratory Society, pp. 282–289, Dec. 01, 2015. doi: 10.1183/20734735.008815.
Article Metrics
Abstract View
: 1115 times
Download : 442 times
Refbacks
- There are currently no refbacks.
